Delayed biosynthesis of varicella-zoster virus glycoprotein C: Upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells

Journal of Virology

Volumn 80, Issue 19, 2006, Pages 9544-9556

  Storlie, Johnathan ^a   Jackson, Wallen ^a   Hutchinson, Jennifer ^a   Grose, Charles ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GLYCOPROTEIN E; HEXAMETHYLENEBISACETAMIDE; HOX PROTEIN; PROTEIN; PROTEIN HOXA9; PROTEIN ORF4; RETINOIC ACID; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN B; VIRUS GLYCOPROTEIN C; VIRUS GLYCOPROTEIN H; VIRUS GLYCOPROTEIN I;

ARTICLE; BIOINFORMATICS; CHICKENPOX; CONSENSUS SEQUENCE; GLYCOPROTEIN SYNTHESIS; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INOCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

ACETAMIDES; CELL LINE; GIANT CELLS; HERPESVIRUS 3, HUMAN; HUMANS; MICROSCOPY, ELECTRON, SCANNING; OPEN READING FRAMES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN BIOSYNTHESIS; TRANSCRIPTION FACTORS; TRETINOIN; UP-REGULATION; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 3; MIRIDAE;

EID: 33748946990     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00668-06     Document Type: Article

References (45)

1. Baudoux, L., P. Defechereux, B. Rentier, and J. Piette. 2000. Gene activation by varicella-zoster virus IE4 protein requires its dimerization and involves both the arginine-rich sequence, the central part, and the carboxyl-terminal cysteine-rich region. J. Biol. Chem. 275:32822-32831.
2. Cartharius, K., K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942.
3. Chao, S. H., J. R. Walker, S. K. Chanda, N. S. Gray, and J. S. Caldwell. 2003. Identification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus. Mol. Cell. Biol. 23:831-841.
4. Cohen, J. I., and K. E. Seidel. 1994. Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin. J. Gen. Virol. 75:3087-3093.
5. David, D. S., B. R. Tegtmeier, M. R. O'Donnell, I. B. Paz, and T. M. McCarty. 1998. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature. Am. J. Gastroenterol. 93:810-813.
6. Douville, P., M. Hagmann, O. Georgiev, and W. Schaffner. 1995. Positive and negative regulation at the herpes simplex virus ICP4 and ICP0 TAATGARAT motifs. Virology 207:107-116.
7. Emini, E. A., J. V. Hughes, D. S. Perlow, and J. Boger. 1985. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J. Virol. 55:836-839.
8. Galle, L. E., N. S. Taus, D. J. Maggs, C. P. Moore, and W. J. Mitchell. 2001. Increased severity of herpes simplex virus type 1-induced keratitis in Hox AS transgenic mice. Curr. Eye Res. 23:435-442.
9. Grose, C. 1994. Congenital infections caused by varicella-zoster virus and herpes simplex virus. Semin. Pediatr. Neurol. 1:43-49.
10. Grose, C. 1981. Variation on a theme by Fenner: the pathogenesis of chicken-pox. Pediatrics 68:735-737.
11. Grose, C., D. P. Edwards, W. E. Friedrichs, K. A. Weigle, and W. L. McGuire. 1983. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect. Immun. 40:381-388.
12. Grose, C., L. Maresova, G. Medigeshi, G. Scott, and G. Thomas. 2006. Endocytosis of varicella-zoster virus glycoproteins: virion envelopment and egress, p. 155-172. In R. Sandri-Goldin (ed.), Alpha herpesviruses: pathogenesis and molecular biology. Horizon Scientific Press, Norfolk, England.
13. Grose, C., D. M. Perrotta, P. A. Brunell, and G. C. Smith. 1979. Cell-free varicella-zoster virus in cultured human melanoma cells. J. Gen. Virol. 43: 15-27.
14. Grose, C., S. Tyler, G. Peters, J. Hiebert, G. M. Stephens, W. T. Ruyechan, W. Jackson, J. Storlie, and G. A. Tipples. 2004. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype. J. Virol. 78:6799-6807.
15. Harson, R., and C. Grose. 1995. Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J. Virol. 69:4994-5010.
16. Hill, G., A. R. Chauvenet, J. Lovato, and T. W. McLean. 2005. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia. Pediatrics 116:e525-e529.
17. Jean, S., K. M. LeVan, B. Song, M. Levine, and D. M. Knipe. 2001. Herpes simplex virus 1 1CP27 is required for transcription of two viral late (gamma 2) genes in infected cells. Virology 283:273-284.
18. Kinchington, P. R., P. Ling, M. Pensiero, A. Gershon, J. Hay, and W. T. Ruyechan. 1990. A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus. Adv. Exp. Med. Biol. 278:83-91.
19. Kinchington, P. R., P. Ling, M. Pensiero, B. Moss, W. T. Ruyechan, and J. Hay. 1990. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J. Virol. 64:4540-4548.
20. Kinchington, P. R., J. Remenick, J. M. Ostrove, S. E. Straus, W. T. Ruyechan, and J. Hay. 1986. Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C. J. Virol. 59:660-668.
21. Levine, M., A. Krikos, J. C. Glorioso, and F. L. Homa. 1990. Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1). Adv. Exp. Med. Biol. 278:151-164.
22. Lungu, O., C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein. 1998. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. USA 95:7080-7085.
23. Mardberg, K., E. Trybala, J. C. Glorioso, and T. Bergstrom. 2001. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. J. Gen. Virol. 82:1941-1950.
24. Mitchell, W., R. De Santo, S. Zhang, W. Odenwald, and H. Arnheiter. 1993. Herpes simplex virus pathogenesis in transgenic mice is altered by the homeodomain protein Hox 1.3. J. Virol. 67:4484-4491.
25. Moffat, J. F., L. Zerboni, P. R. Kinchington, C. Grose, H. Kaneshima, and A. M. Arvin. 1998. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:965-974.
26. Panagopoulos, I., M. Isaksson, R. Billstrom, B. Strombeck, F. Mitelman, and B. Johansson. 2003. Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13). Genes Chromosomes Cancer 36:107-112.
27. Pasieka, T. J., L. Maresova, K. Shiraki, and C. Grose. 2004. Regulation of varicella-zoster virus-induced cell-to-cell fusion by the endocytosis-competent glycoproteins gH and gE. J. Virol. 78:2884-2896.
28. Perera, L. P., J. D. Mosca, M. Sadeghi-Zadeh, W. T. Ruyechan, and J. Hay. 1992. The varicella-zoster virus immediate-early protein, IE62, can positively regulate its cognate promoter. Virology 191:346-354.
29. Preston, C. M., and M. McFarlane. 1998. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Virology 249:418-426.
30. Qin, P., R. Cimildoro, D. M. Kochhar, K. J. Soprano, and D. R. Soprano. 2002. PBX, MEIS, and IGF-I are potential mediators of retinoic acid-induced proximodistal limb reduction defects. Teratology 66:224-234.
31. Qin, P., J. M. Haberbusch, K. J. Soprano, and D. R. Soprano. 2004. Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and posttranslationally. J. Cell Biochem. 92:147-163.
32. Qin, P., J. M. Haberbusch, Z. Zhang, K. J. Soprano, and D. R. Soprano. 2004. Pre-B cell leukemia transcription factor (PBX) proteins are important mediators for retinoic acid-dependent endodermal and neuronal differentiation of mouse embryonal carcinoma P19 cells. J. Biol. Chem. 279:16263-16271.
33. Sagerstrom, C. G. 2004. PbX marks the spot. Dev. Cell 6:737-738.
34. Santos, R. A., J. A. Padilla, C. Hatfield, and C. Grose. 1998. Antigenic variation of varicella-zoster virus Fc receptor gE: loss of a major B-cell epitope in the ectodomain. Virology 249:21-31.
35. Schwartz, J. A., E. E. Brittle, A. E. Reynolds, L. W. Enquist, and S. J. Silverstein. 2006. UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture. J. Virol. 80:769-784.
36. Shen, W. F., S. Rozenfeld, A. Kwong, L. G. Kom ves, H. J. Lawrence, and C. Largman. 1999. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol. Cell. Biol. 19:3051-3061.
37. Shukla, D., and P. G. Spear. 2001. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Investig. 108:503-510.
38. Stingley, S. W., J. J. G. Ramirez, S. A. Aguilar, K. Simmen, R. M. Sandri-Goldin, P. Ghazal, and E. K. Wagner. 2000. Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J. Virol. 74:9916-9927.
39. Subramaniam, N., J. Campion, I. Rafter, and S. Okret. 2003. Cross-talk between glucocorticoid and retinoic acid signals involving glucocorticoid receptor interaction with the homoeodomain protein Pbx1. Biochem. J. 370:1087-1095.
40. Sugano, T., T. Tomiyama, Y. Matsumoto, S. Sasaki, T. Kimura, B. Forghani, and Y. Masuho. 1991. A human monoclonal antibody against varicella-zoster virus glycoprotein III. J. Gen. Virol. 72:2065-2073.
41. Swain, M. A., R. W. Peet, and D. A. Galloway. 1985. Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart. J. Virol. 53:561-569.
42. Taylor, S. L., P. R. Kinchington, A. Brooks, and J. F. Moffat. 2004. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicellazoster virus. J. Virol. 78:2853-2862.
43. Vijapurkar, U., N. Fischbach, W. Shen, C. Brandts, D. Stokoe, H. J. Lawrence, and C. Largman. 2004. Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation. Mol. Cell. Biol. 24:3827-3837.
44. Weigle, K. A., and C. Grose. 1983. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J. Infect. Dis. 148:630-638.
45. Yang, W. C., G. V. Devi-Rao, P. Ghazal, E. K. Wagner, and S. J. Triezenberg. 2002. General and specific alterations in programming of global viral gene expression during infection by VP16 activation-deficient mutants of herpes simplex virus type 1. J. Virol. 76:12758-12774.